Q1 2024 13F Holders as of 31 Mar 2024
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
110,897,279
-
Number of holders
-
102
-
Total 13F shares, excl. options
-
36,616,859
-
Shares change
-
+15,126,299
-
Total reported value, excl. options
-
$903,617,775
-
Value change
-
+$377,900,927
-
Put/Call ratio
-
70%
-
Number of buys
-
85
-
Number of sells
-
22
-
Price
-
$24.68
Institutional Holders of Immunome Inc. - Common Stock, par value $0.0001 per share (IMNM) as of Q1 2024
As of 31 Mar 2024 Immunome Inc. - Common Stock, par value $0.0001 per share (IMNM) had 102 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 36,616,859 shares of stock of the company.
Largest 10 holders included Redmile Group, LLC, FMR LLC, EcoR1 Capital, LLC, PRICE T ROWE ASSOCIATES INC /MD/, VANGUARD GROUP INC, Point72 Asset Management, L.P., JANUS HENDERSON GROUP PLC, T. Rowe Price Investment Management, Inc., Woodline Partners LP, and Avidity Partners Management LP.
This table shows 102 institutional shareholders of the security as of 31 Mar 2024.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.